The federal judge who ruled last month that the Affordable Care Act (ACA) was invalid issued an order over the weekend that the law will remain in effect pending appeal; pharmacies and businesses with pharmacies in New York City will no longer be allowed to sell cigarettes and other tobacco products; a federal judge has blocked the administration's cut to the 340B program.
The federal judge who ruled last month that the Affordable Care Act was unconstitutional issued a stay over the weekend, which will keep the law in effect while the ruling is appealed. According to The New York Times, Judge Reed O’Connor of the Federal District Court in Fort Worth, Texas, said that the ruling would not go into immediate effect “because many everyday Americans would otherwise face great uncertainty” during the appeal.
Starting this week, pharmacies and businesses that contain pharmacies, such as supermarkets, will be banned from selling cigarettes and other tobacco products in New York City, reported The Wall Street Journal. Affecting approximately 500 pharmacies, the change will reduce the total number of retailers licensed to sell tobacco by about 6.4%. Health officials in the city praised the decision, calling it an important step in reducing the number of smokers in New York.A federal judge has blocked the Trump administration’s cut to the 340B Drug Discount Program, ruling that the administration illegally reduced Medicare payments to the program and that the rule went against Congress’s intent when it approved the program, reported The Hill. The rule, which went into effect last January, cut payments by 30%. When the rule was issued, the administration argued that the changes would reduce out-of-pocket costs Medicare patients pay for outpatient drugs. However, hospitals argued that the changes would threaten critical services they provide to underserved populations.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More